By modulating the cellular senescence through E2F/miR-106b-5p/p21 axis, Dong et al. found a novel mechanism by which BRD4 regulated cancer cell proliferation and provided new insights into using BET inhibitors as potential anticancer drugs12. This evidence concerns the gene BRD4 and cancer.